Glenmark Life Sciences Limited IPO
Mainboard₹14,400 / 20 Shares
Glenmark Life Sciences Limited IPO Details
The Glenmark Life Sciences Limited IPO price band is set between ₹695-720 per equity share, with a face value of ₹2 per share. The issue is managed by KFintech Private Limited, and the equity shares are proposed to be listed on the Mainboard.
The IPO date for subscription opens on 27 Jul, 2021 and closes on 29 Jul, 2021. Investors can check the allotment status on 3 Aug, 2021, while the listing date is tentatively scheduled for 6 Aug, 2021.
The total issue size is 1513.60 Crore; 1060 Crore Fresh Issue + 453.60 Crore Offer for Sale of 63,00,000 Shares, aggregating up to . Stay tuned for the latest Glenmark Life Sciences Limited IPO review and GMP updates.
Glenmark Life Sciences Limited IPO Review, Rating & Analysis
Glenmark Life Sciences Limited IPO Review
NO REVIEWGlenmark Life Sciences Limited IPO Rating
Glenmark Life Sciences Limited IPO Highlights
IPO Date
Jul 27, 2021 - Jul 29, 2021
Listing Date
6 Aug, 2021
Face Value
₹2 Per Equity Share
Price Band
₹695-720 per equity share
Lot Size
-
Fresh Issue
Shares
Offer for Sale
-
Listing At
BSE, NSE
Glenmark Life Sciences Limited IPO Lot Size
The minimum market lot for Glenmark Life Sciences Limited IPO is 20 shares with an application amount of ₹14,400. Retail investors can apply for up to 13 lots. The table below details the minimum and maximum investment limits for Retail and HNI investors.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 20 | ₹14,400 |
| Retail (Max) | 13 | 260 | ₹1,87,200 |
| S-HNI (Min) | 14 | 280 | ₹2,01,600 |
| S-HNI (Max) | 69 | 1380 | ₹9,93,600 |
| B-HNI (Min) | 70 | 1400 | ₹10,08,000 |
Glenmark Life Sciences Limited IPO Timeline
Issue Price
₹695-720 per equity shareFace Value
₹2 Per Equity ShareListing at Group
BSE, NSERegistrar
KFintech Private LimitedLead Manager
BoA Merrill Lynch, BOB Capital Markets Limited, DAM Capital Advisors Ltd (Formerly IDFC Securities Ltd), Goldman Sachs (India) Securities Private Limited, Kotak Mahindra Capital Company Limited, SBI Capital Markets LimitedIssue Size
1513.60 Crore; 1060 Crore Fresh Issue + 453.60 Crore Offer for Sale of 63,00,000 SharesGlenmark Life Sciences Limited IPO Financial Information
| Period Ended | Assets | Revenue | Profit After Tax | Net Worth | Reserves and Surplus | Total Borrowing |
|---|---|---|---|---|---|---|
| 31 Mar 21 | 1997.07 | 1885.97 | 351.58 | - | - | - |
| 31 Mar 20 | 1725.60 | 1549.30 | 313.09 | - | - | - |
| 31 Mar 19 | 1475.39 | 886.86 | 195.59 | - | - | - |
All values are in ₹ Cr.
Promoters & Share Holding
Promoter(s) Name
- Glenmark Pharmaceuticals Limited
| Share Holding Pre Issue | Share Holding Post Issue |
|---|---|
| 100% | 82.84% |
About Company
Glenmark Life Sciences is the leading manufacturer of Active Pharmaceutical Ingredients (APIs). The company develops, manufactures, and supplies high-quality APIs for cardiovascular disease (CVS), central nervous system disease (CNS), pain management, and diabetes, gastrointestinal disorders, anti-infectives, and other therapeutic areas. It further operates in Contract Development and manufacturing operations (CDMO) to offer services to specialty Pharmaceutical companies.
Its products are being sold in India and also expoted to multiple countries i.e. Europe, North America, Latin America, Japan, etc. Currently, it has 4 manufacturing facilities at Ankleshwar and Dahej in Gujarat and Mohol and Kurkumbh in Maharashtra State with an aggregate annual installed capacity of 725.8 KL as of December 31, 2020.
Glenmark Life Sciences Limited IPO Subscription Details
| As on | QIB | NII bNII sNII | Retail | Total |
|---|---|---|---|---|
| Shares Offered / Reserved | 42,42,379 | 32,32,770 | 75,43,130 | 1,50,18,279 |
Day 1 -27-07-20 05:00 PM | 0.00 x | 0.85 | 5.17 x | 2.78 x |
Day 2 -28-07-20 05:00 PM | 1.40 x | 3.48 | 9.51 x | 5.90 x |
Day 3 -29-07-20 05:00 PM | 37.30 x | 125.62 | 15.00 x | 45.08 x |
10.74 times
Frequently Asked Questions about Glenmark Life Sciences Limited IPO IPO
When will Glenmark Life Sciences Limited IPO open for subscription?
The Glenmark Life Sciences Limited IPO opens on 27 Jul, 2021 and closes on 29 Jul, 2021.
What is the investors portion for Glenmark Life Sciences Limited IPO?
The investors' portion for QIB is 37.30 x, NII is 125.62, and Retail is 15.00 x.
How to apply for Glenmark Life Sciences Limited IPO?
You can apply for Glenmark Life Sciences Limited IPO via ASBA online through your bank account. You can also apply via UPI through stock brokers like Zerodha, Upstox, or Paytm Money.
What is the issue size of Glenmark Life Sciences Limited IPO?
The issue size of Glenmark Life Sciences Limited IPO is approx ₹1513.60 Crore; 1060 Crore Fresh Issue + 453.60 Crore Offer for Sale of 63,00,000 Shares crores.
What is the price band of Glenmark Life Sciences Limited IPO?
The price band for Glenmark Life Sciences Limited IPO is ₹695 to ₹720 per equity share.
What is the lot size of Glenmark Life Sciences Limited IPO?
The minimum bid (lot size) for Glenmark Life Sciences Limited IPO is N/A shares with an investment of approx ₹14,400 .
What is the allotment date of Glenmark Life Sciences Limited IPO?
The allotment date for Glenmark Life Sciences Limited IPO is 3 Aug, 2021.
What is the listing date of Glenmark Life Sciences Limited IPO?
The listing date for Glenmark Life Sciences Limited IPO is expected to be 6 Aug, 2021.
What is the GMP of Glenmark Life Sciences Limited IPO?
The latest Grey Market Premium (GMP) for Glenmark Life Sciences Limited IPO is being updated regularly on IPOROCK.
Parth D.
Founder & Lead Analyst
Parth D. is a software engineer and financial analyst who brings a quantitative edge to IPO tracking. With deep expertise in algorithmic trading and financial tool development, he builds the technology that powers IPORock's real-time data engines. He has been tracking the Indian market since 2018.